- Home
- AERT vs TENX Comparison
AERT vs TENX Comparison
Compare AERT & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AERT
- TENX
- Stock Information
- Founded
- AERT 2012
- TENX 1967
- Country
- AERT Singapore
- TENX United States
- Employees
- AERT N/A
- TENX N/A
- Industry
- AERT Professional Services
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- AERT Consumer Discretionary
- TENX Health Care
- Exchange
- AERT Nasdaq
- TENX Nasdaq
- Market Cap
- AERT 25.4M
- TENX 21.7M
- IPO Year
- AERT N/A
- TENX N/A
- Fundamental
- Price
- AERT $0.74
- TENX $5.46
- Analyst Decision
- AERT
- TENX Strong Buy
- Analyst Count
- AERT 0
- TENX 3
- Target Price
- AERT N/A
- TENX $16.00
- AVG Volume (30 Days)
- AERT 75.9K
- TENX 18.4K
- Earning Date
- AERT 05-20-2025
- TENX 05-13-2025
- Dividend Yield
- AERT N/A
- TENX N/A
- EPS Growth
- AERT N/A
- TENX N/A
- EPS
- AERT 0.47
- TENX N/A
- Revenue
- AERT $70,851,000.00
- TENX N/A
- Revenue This Year
- AERT N/A
- TENX N/A
- Revenue Next Year
- AERT N/A
- TENX N/A
- P/E Ratio
- AERT $1.53
- TENX N/A
- Revenue Growth
- AERT 4.38
- TENX N/A
- 52 Week Low
- AERT $0.46
- TENX $2.77
- 52 Week High
- AERT $2.93
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- AERT 60.63
- TENX 42.57
- Support Level
- AERT $0.69
- TENX $4.63
- Resistance Level
- AERT $0.73
- TENX $5.75
- Average True Range (ATR)
- AERT 0.08
- TENX 0.42
- MACD
- AERT 0.01
- TENX -0.04
- Stochastic Oscillator
- AERT 80.80
- TENX 47.70
About AERT Aeries Technology Inc.
Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.